Journal articles on the topic 'Anti-tumor agent'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Anti-tumor agent.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Chen, Weicui, Bo Liu, Jun Chen, Guoqing Liu, and Xian Liu. "Targeted tumor MRI with gadobutrol-loaded anti-HER2 immunoliposomes." Acta Radiologica 58, no. 5 (2016): 573–80. http://dx.doi.org/10.1177/0284185116664225.
Full textFareed, Jawed, Angel Gray, Daniel Kahn, et al. "The effect of tissue factor pathway inhibitor release and interactions with growth factors on the antitumor effects of ultra low molecular weight heparin semuloparin." Journal of Clinical Oncology 30, no. 15_suppl (2012): e13117-e13117. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e13117.
Full textYamamoto, Satoshi, Eriko Aizu, Hong Jiang, et al. "The potent anti-tumor-promoting agent isoliquiritigenin." Carcinogenesis 12, no. 2 (1991): 317–23. http://dx.doi.org/10.1093/carcin/12.2.317.
Full textWang, X. L., B. Q. Fu, S. J. Yang, et al. "Trichinella spiralis—A potential anti-tumor agent." Veterinary Parasitology 159, no. 3-4 (2009): 249–52. http://dx.doi.org/10.1016/j.vetpar.2008.10.052.
Full textOBATA, Rika, and Takeshi OHNUMA. "Electrochemical Oxidation of Anti-tumor Agent, Etoposide." CHEMICAL & PHARMACEUTICAL BULLETIN 41, no. 10 (1993): 1846–47. http://dx.doi.org/10.1248/cpb.41.1846.
Full textRajabi, Mehdi, Mary Adeyeye, and Shaker A. Mousa. "Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer." Current Medicinal Chemistry 26, no. 30 (2019): 5664–83. http://dx.doi.org/10.2174/0929867326666190620100800.
Full textVillegas-Vázquez, Edgar Yebrán, Laura Itzel Quintas-Granados, Hernán Cortés, et al. "Lithium: A Promising Anticancer Agent." Life 13, no. 2 (2023): 537. http://dx.doi.org/10.3390/life13020537.
Full textKakodkar, Nisha C., Radhika Peddinti, Morris Kletzel, et al. "The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growth." Pediatric Blood & Cancer 56, no. 1 (2010): 164–67. http://dx.doi.org/10.1002/pbc.22639.
Full textLinot, Camille, Jasmeen Saini, and Prasad S. Adusumilli. "Sustained, cell-intrinsic versus intermittent, cell-extrinsic checkpoint blockade in solid tumor CAR T-cell therapy." Journal of Clinical Oncology 38, no. 5_suppl (2020): 16. http://dx.doi.org/10.1200/jco.2020.38.5_suppl.16.
Full textSamuel, Samson, Elizabeth Varghese, Peter Kubatka, Chris Triggle, and Dietrich Büsselberg. "Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer." Biomolecules 9, no. 12 (2019): 846. http://dx.doi.org/10.3390/biom9120846.
Full textLee, Jin-Young, Whasun Lim, and Gwonhwa Song. "Tumor-suppressive function of methiothepin in human placental choriocarcinoma cells." Reproduction 160, no. 6 (2020): 919–29. http://dx.doi.org/10.1530/rep-20-0377.
Full textZheng, Yi-Dan, Ying Zhang, Jun-Yi Ma, Chun-Yan Sang, and Jun-Li Yang. "A Carabrane-Type Sesquiterpenolide Carabrone from Carpesium cernuum Inhibits SW1990 Pancreatic Cancer Cells by Inducing Ferroptosis." Molecules 27, no. 18 (2022): 5841. http://dx.doi.org/10.3390/molecules27185841.
Full textYegodayev, Ksenia M., and Moshe Elkabets. "Development of a AXL/PD-1 BiCE as novel immunotherapy agent." South East European Journal of Immunology 8, CITIM (2025): 034. https://doi.org/10.3889/seejim.2025.6095.
Full textMenéndez-Menéndez, Javier, and Carlos Martínez-Campa. "Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers." International Journal of Endocrinology 2018 (October 2, 2018): 1–20. http://dx.doi.org/10.1155/2018/3271948.
Full textDorr, Robert T., Betty K. Samulitis, Lee Wisner, et al. "Characterization of a membrane-active anti-tumor agent, UA8967." Investigational New Drugs 31, no. 3 (2012): 576–86. http://dx.doi.org/10.1007/s10637-012-9901-z.
Full textCai, Zhun, Chenyang Mao, Yeqing Wang, et al. "Research Progress with Luteolin as an Anti-Tumor Agent." Natural Product Communications 17, no. 11 (2022): 1934578X2211335. http://dx.doi.org/10.1177/1934578x221133579.
Full textWu, L., W. Liu, C. Galustian, P. Schafer, A. G. Dalgleish, and J. B. Bartlett. "Effect of lenalidomide on the antiproliferative effect of gemcitabine against pancreatic tumor cells and on immune-mediated pancreatic cancer cell death." Journal of Clinical Oncology 27, no. 15_suppl (2009): e14635-e14635. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e14635.
Full textSelvanesan, Benson Chellakkan, Alvaro de Mingo Pulido, Sheelu Varghese, et al. "NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor Models." Cancers 15, no. 5 (2023): 1468. http://dx.doi.org/10.3390/cancers15051468.
Full textGerber, Hans-Peter, and Napoleone Ferrara. "Pharmacology and Pharmacodynamics of Bevacizumab as Monotherapy or in Combination with Cytotoxic Therapy in Preclinical Studies." Cancer Research 65, no. 3 (2005): 671–80. http://dx.doi.org/10.1158/0008-5472.671.65.3.
Full textGephart, Benjamin D., Don W. Coulter, and Joyce C. Solheim. "Effects of the Alkylating Agent Cyclophosphamide in Potentiating Anti-Tumor Immunity." International Journal of Molecular Sciences 26, no. 13 (2025): 6440. https://doi.org/10.3390/ijms26136440.
Full textBennett, Kaila M., Jacob P. Matson, Sylwia Stopka, et al. "Abstract 6161: Exploring BRG399, a novel microtubule-binding agent, as an inducer of immunogenic cell death in cancer therapy." Cancer Research 85, no. 8_Supplement_1 (2025): 6161. https://doi.org/10.1158/1538-7445.am2025-6161.
Full textFelińska, Zuzanna, Julia Silldorff, Tomasz Fura, et al. "Ulcerative colitis - ustekinumab as a new biologic therapy, review 2024." Quality in Sport 17 (August 16, 2024): 53670. http://dx.doi.org/10.12775/qs.2024.17.53670.
Full textOshikawa, Tetsuya, Masato Okamoto, Tomoyuki Tano, et al. "Involvement of nitric oxide in anti-tumor effects of OK-432, a streptococcal anti-tumor immunotherapeutic agent." International Immunopharmacology 6, no. 5 (2006): 764–73. http://dx.doi.org/10.1016/j.intimp.2005.11.010.
Full textLiang, Jiabao, Tong Wen, Xiaojian Zhang, and Xiaoling Luo. "Chlorogenic Acid as a Potential Therapeutic Agent for Cholangiocarcinoma." Pharmaceuticals 17, no. 6 (2024): 794. http://dx.doi.org/10.3390/ph17060794.
Full textLuchtel, Rebecca A., Tushar Bhagat, Kith Pradhan, et al. "High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model." Proceedings of the National Academy of Sciences 117, no. 3 (2020): 1666–77. http://dx.doi.org/10.1073/pnas.1908158117.
Full textDahlem, Charlotte, Wei Xiong Siow, Maria Lopatniuk, et al. "Thioholgamide A, a New Anti-Proliferative Anti-Tumor Agent, Modulates Macrophage Polarization and Metabolism." Cancers 12, no. 5 (2020): 1288. http://dx.doi.org/10.3390/cancers12051288.
Full textJin, Chengwen, Mingyuan Yuan, Hualei Bu, and Chengjuan Jin. "Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy." Journal of Oncology 2022 (April 12, 2022): 1–15. http://dx.doi.org/10.1155/2022/4880355.
Full textMiyake, Yasuhiro, Hiroshi Matsushita, and Kazuhide Yamamoto. "Anti-60S ribosomal protein L29 antibody: New anticancer agent discovered from human sera." Journal of Clinical Oncology 31, no. 15_suppl (2013): 3071. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.3071.
Full textSchaefer, Christopher W., Deepika Lal, R. Robert Vethanayagam, Joseph A. Spernyak, Mukund Seshadri, and Eunice S. Wang. "Anti-Vascular and Anti-Tumor Effects of the Vascular Disrupting Agent ASA404 (DMXAA) in Human Acute Leukemia Xenograft Models." Blood 118, no. 21 (2011): 4293. http://dx.doi.org/10.1182/blood.v118.21.4293.4293.
Full textSanna, Daniele, Maria Serra, Valeria Ugone, et al. "Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride." Metallomics 8, no. 5 (2016): 532–41. http://dx.doi.org/10.1039/c6mt00002a.
Full textJiang, Hong, Satoshi Yamamoto, Kiyotako Nishikawa, and Ryuichi Kato. "Anti-tumor-promoting action of FK506, a potent immunosuppressive agent." Carcinogenesis 14, no. 1 (1993): 67–71. http://dx.doi.org/10.1093/carcin/14.1.67.
Full textJiang, Hong, Satoshi Yamamoto, Kiyotaka Nishikawa, and Ryuichi Kato. "Anti-tumor-promoting action of FK506, a potent immunosuppressive agent." Japanese Journal of Pharmacology 58 (1992): 160. http://dx.doi.org/10.1016/s0021-5198(19)48980-4.
Full textMelendez, Robert, Joseph Harrison, Eric Rowinsky, Lisa Hammond, and Thomas Fitzsimmons. "Acute retinal toxicity from the novel anti-tumor agent, Irofulven." Documenta Ophthalmologica 108, no. 3 (2004): 249–51. http://dx.doi.org/10.1007/s10633-004-4085-2.
Full textEugenio Gaudio, Chiara Tarantelli, Filippo Spriano, et al. "Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models." Haematologica 105, no. 11 (2020): 2584–91. http://dx.doi.org/10.3324/haematol.2019.227215.
Full textXia, Yi, Fuling Zhou, Liang Kong та ін. "Primary analysis of a phase 1/2 study of LM-101: An anti-SIRPα antibody as a single agent in patients with advanced malignancies." Journal of Clinical Oncology 42, № 16_suppl (2024): 2640. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.2640.
Full textChaibi, Assia, Christophe Rey, Alban Bessede, and Imane Nafia. "Abstract B074: Enhanced anti-tumor response to anti-angiogenic/hypoxia-regulating therapies in combination with immune checkpoint blockade in a murine model of renal carcinoma." Cancer Immunology Research 13, no. 2_Supplement (2025): B074. https://doi.org/10.1158/2326-6074.io2025-b074.
Full textRaben, David, Cataldo Bianco, Vincenzo Damiano, et al. "Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model." Molecular Cancer Therapeutics 3, no. 8 (2004): 977–83. http://dx.doi.org/10.1158/1535-7163.977.3.8.
Full textPollard, Rachel E., Amy R. Sadlowski, Susannah H. Bloch, et al. "Contrast-assisted Destruction-replenishment Ultrasound for the Assessment of Tumor Microvasculature in a Rat Model." Technology in Cancer Research & Treatment 1, no. 6 (2002): 459–70. http://dx.doi.org/10.1177/153303460200100606.
Full textValantin, Marc-Antoine, Léna Royston, Maxime Hentzien, et al. "Therapeutic Perspectives in the Systemic Treatment of Kaposi’s Sarcoma." Cancers 14, no. 3 (2022): 484. http://dx.doi.org/10.3390/cancers14030484.
Full textZhang, M., J. Huck, M. Hyer, J. Ecsedy, and M. Manfredi. "Effect of Aurora A kinase inhibitor MLN8237 combined with rituximab on antitumor activity in preclinical B-cell non-Hodgkin's lymphoma models." Journal of Clinical Oncology 27, no. 15_suppl (2009): 8553. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.8553.
Full textNeuwelt, E. A., and E. Frenkel. "The paradoxical effect of targeted antivascular agents in the therapy of CNS malignancies." Journal of Clinical Oncology 27, no. 15_suppl (2009): 2013. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.2013.
Full textLindquist, Jeffrey N., Kai Qin, Aaron M. Ring, and Hirdesh Uppal. "Abstract 4073: Decoy-resistant IL-18 enhances checkpoint inhibitor combinations beyond anti-PD-1 in vitro and in vivo." Cancer Research 84, no. 6_Supplement (2024): 4073. http://dx.doi.org/10.1158/1538-7445.am2024-4073.
Full textDu, Yong, Aditya Kulkarni, Jianli Zhou, Hui Dai, Kishor Bhatia, and Shiaw-Yih Lin. "Abstract A044: LP-184, a Novel Acylfulvene, Sensitizes Immuno-refractory Triple-Negative Breast Cancers (TNBCs) To Anti-PD1 Therapy by Affecting the Tumor Microenvironment." Cancer Immunology Research 13, no. 2_Supplement (2025): A044. https://doi.org/10.1158/2326-6074.io2025-a044.
Full textKwong, Brandon, Haipeng Liu, and Darrell Irvine. "Intratumoral delivery of liposome-anchored anti-CD137 and IL-2 induces highly potent local and systemic anti-tumor immunity while minimizing toxic inflammatory side effects (165.6)." Journal of Immunology 188, no. 1_Supplement (2012): 165.6. http://dx.doi.org/10.4049/jimmunol.188.supp.165.6.
Full textRice, Audie G., Myles B. C. Dillon, Anne M. Van Abbema, and Daniel E. H. Afar. "HuLuc63 in Combination Regimens with Conventional and Targeted Therapies Has Additive and Synergistic Anti-Tumor Activity in Pre-Clinical Models of Myeloma." Blood 110, no. 11 (2007): 2517. http://dx.doi.org/10.1182/blood.v110.11.2517.2517.
Full textWang, Ju Bo, Mao De Wang, En Xiao Li, and Dan Feng Dong. "Advances and prospects of anginex as a promising anti-angiogenesis and anti-tumor agent." Peptides 38, no. 2 (2012): 457–62. http://dx.doi.org/10.1016/j.peptides.2012.09.007.
Full textTachibana, Tomoko, Tomoko Gowa Oyama, Yukie Yoshii, et al. "An In Vivo Dual-Observation Method to Monitor Tumor Mass and Tumor-Surface Blood Vessels for Developing Anti-Angiogenesis Agents against Submillimeter Tumors." International Journal of Molecular Sciences 24, no. 24 (2023): 17234. http://dx.doi.org/10.3390/ijms242417234.
Full textCooper, Jalyn, Dheeraj Kodali, and Gerald M. Higa. "Acute encephalopathy with combination dabrafenib/trametinib therapy." Journal of Oncology Pharmacy Practice 23, no. 4 (2016): 313–17. http://dx.doi.org/10.1177/1078155216638551.
Full textYigit, Burcu, Xavier Michelet, Shalu Kharkwal, et al. "164 AgenT-797, a novel allogenic and ‘off-the shelf’ iNKT cell therapy promotes effective tumor killing." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (2020): A177. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0164.
Full textCapello, Michela, Angelica Sette, Theo Plantinga, et al. "Abstract 3283: GEN1046 (DuoBody®-PD-L1x4-1BB) in combination with PD-1 blockade potentiates anti-tumor immunity." Cancer Research 83, no. 7_Supplement (2023): 3283. http://dx.doi.org/10.1158/1538-7445.am2023-3283.
Full text